drugset / Trial / NCT04951362

Role of Ivermectin Nanosuspension as Nasal Spray in Treatment of Persistant Post covid19 Anosmia

NCT04951362

Phase 2/3 Unknown 117 enrolled South Valley University
RandomizedParallel-groupOpen-labelTreatment

Summary

ivermectin is FDA approaved antiparasitic drug which is also claimed to be having potent in vitro antiviral effect,so we are tryying to study itsovid19 anosmia effect upon releiving post covid19 anosmia

Timeline

Start
2021-04-20
Primary completion
2022-05-12
Completion
2022-05-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ivermectin Small molecule Intranasal

Indications